Could a daily ultrasound zap arthritis pain at home?

NCT ID NCT07163221

Recruiting now Disease control Sponsor: SecondWave Systems Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a non-invasive device that uses ultrasound to stimulate the spleen and reduce inflammation in people with moderate to severe rheumatoid arthritis. About 60 adults who haven't responded well to standard medications will use the device at home for 12 weeks, with some receiving a sham treatment for comparison. The goal is to see if this approach can safely lower disease activity without the need for lifelong drugs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RHEUMATOID ARTHRITIS (RA)

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Arizona Arthritis and Rheumatology Associates P.C.
ACTIVE_NOT_RECRUITING

Glendale, Arizona, 85306, United States
Medvin Clinical Research
ACTIVE_NOT_RECRUITING

Covina, California, 91722, United States
Southland Arthritis & Osteoporosis Medical Center
ACTIVE_NOT_RECRUITING

Temecula, California, 92592, United States
University of Colorado
ACTIVE_NOT_RECRUITING

Aurora, Colorado, 80045, United States
University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases
RECRUITING

Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.